Electrospray ionization is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Last reviewed on 2025-12-29. Where a claim depends on a specific study, the study is described rather than over-claimed.
Published studies examine a fairly narrow set of endpoints. Rodent experiments commonly measure maze learning, infarct volume after induced ischemia, and tissue levels of neurotrophic factors. Clinical reports from Russian centres describe attention, memory and recovery scores in patients after stroke or transient ischemic attack. Most of those human studies are small and few have been repeated by independent groups. Outcome measures differ between studies, which limits direct comparison.
Circulation time for the peptide is short because peptidases cleave it readily. The Pro-Gly-Pro tail is thought to slow breakdown compared with the bare ACTH fragment, but the gain appears modest. Absorption after intranasal dosing is limited, and only a fraction of a dose is expected to reach the central nervous system. Laboratory concentrations therefore sit well above levels achieved systemically, a gap that complicates translation from bench findings to clinical claims.
The mechanisms attributed to semax are inferred from animal and cell studies rather than traced to one confirmed target. The most frequently cited pathway involves increased expression of brain-derived neurotrophic factor and nerve growth factor in hippocampal and cortical tissue. Some work points to engagement of melanocortin receptors, particularly MC4, which the parent ACTH fragment can activate. Effects on dopaminergic and serotonergic signalling have also been reported. No single account explains all observed results, and the relative weight of each pathway remains unsettled.
Identity and purity of Semax are established mainly by reversed-phase high-performance liquid chromatography coupled with mass spectrometry. The chromatographic trace gives a purity estimate as a percentage of total peak area, while electrospray or matrix-assisted laser desorption ionization confirms the molecular mass against the calculated value. Amino acid analysis and sequence-specific fragmentation provide further confirmation when a supplier's chain of custody is unclear. Vendors frequently quote a purity figure without stating the detection wavelength or the integration method, which limits how far one number can be compared with another.
Stability depends heavily on physical state. Lyophilized powder held dry, cold and dark retains its content over long periods, whereas dissolved peptide begins to change within days at room temperature. The most cited degradation route is oxidation of the methionine residue, which converts the peptide to a sulfoxide form that elutes differently on chromatography. Hydrolysis of amide bonds and adsorption onto container walls contribute smaller losses. Buffers that exclude oxygen from the headspace slow the oxidation pathway, but no single condition prevents all change indefinitely.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Lyophilized solid from research suppliers |
| Solubility | Freely soluble in water | Also dissolves in aqueous buffers; solutions are used fresh |
| Typical storage temperature | -20 °C for lyophilized powder | Short-term transport at 2-8 °C is common |
| Common analytical method | Reverse-phase HPLC | Paired with mass spectrometry for identity confirmation |
| Common synonyms | ACTH(4-10) analogue; MEHFPGP | N-terminal methionine retained in the chain |
== Types == Popliteal pterygium syndrome, a congenital condition affecting the face, limbs, or genitalia but named after the wing-like structural anomaly behind the knee. Pterygium (eye) or surfer's eye, a growth on the cornea of the eye. Pterygium colli or webbed neck, a congenital skin fold of the neck down to the shoulders. Pterygium inversum unguis or ventral pterygium, adherence of the distal portion of the nailbed to the ventral surface of the nail plate. Pterygium unguis or dorsal pterygium, scarring between the proximal nail fold and matrix.
This page is a list of Russian drugs, or drugs that were developed in Russia, the former Soviet Union, and/or post-Soviet countries. Many Russian drugs are indicated for enhancing physical, mental, and/or cognitive performance, including drugs described as nootropics or cognitive enhancers, drugs combatting fatigue, so-called adaptogens or actoprotectors, and others. There have been concerns about Russian drugs in the Western world owing to allegedly lower standards of medical evidence in Russia compared to the West, for instance in the case of the Russian COVID vaccine Sputnik V. Some Russian drugs have been attempted to be repurposed and developed by pharmaceutical companies for use in the West, such as phenylpiracetam (fonturacetam), (R)-phenylpiracetam (MRZ-9547), Noopept (omberacetam), and armesocarb (the active enantiomer of mesocarb).
=== Labeling === For US food and dietary supplement labeling purposes, the amount in a serving is expressed as a percent of Daily Value. Since 27 May 2016, the Daily Value has been 1.2 mg, in line with the RDA.
Sources: en.wikipedia.org
=== Soviet disintegration === Political scientist Alex Pravda frames the Soviet collapse as unfolding in two acts: an initial phase, from 1989 to 1990, driven by smaller republics in the Baltic and Caucasus seeking sovereignty, followed by a second, from late 1990 through 1991, in which the defection of larger republics—Ukraine and, decisively, Russia under Boris Yeltsin—eroded the center's capacity to hold the union together. For Pravda, the USSR's demise was overwhelmingly domestic in origin, driven by ethnic nationalist movements that flourished under perestroika's liberalized conditions and were seized upon by republican elites contesting a Kremlin weakened by economic crisis; the international dimension of the Cold War's end played, in his assessment, only a secondary role. The collapse of the Eastern European governments with Gorbachev's tacit consent inadvertently encouraged several Soviet republics to seek greater independence from Moscow's rule. Agitation for independence in the Baltic states led to first Lithuania, and then Estonia and Latvia, declaring their independence. Disaffection in the other republics was met by promises of greater decentralization. More open ballots led to the election of candidates opposed to the Communist Party of the Soviet Union, but it also contributed to party fragmentation and presidentialism, which complicated democratic transition. Washington's confidence in the Soviet Union's survival outlasted Moscow's own. Visiting Kiev on 1 August 1991, George Bush Sr.
=== Proposals for housing affordability === In January 2026, Trump proposed several actions and policies to make housing more affordable. These included the banning of "large institutional investors" from buying single-family homes, buying up to $200 billion of mortgage debt in order to reduce mortgage interest rates [already started earlier in the month], making 50-year mortgages available, making portable mortgages available, and allowing homebuyers to use their 401(k)s plans for down payments. Critics say the housing shortage is the number one reason for higher prices and that addressing this shortage will take a number of state and local actions. Critics also say that making portable mortgages available would give existing homeowners an even bigger advantage over first-time buyers. In January 2026, Trump announced that he had ordered Fannie Mae and Freddie Mac to buy up to $200 billion in mortgage-backed bonds to drive down interest rates for new mortgages. The interest rates have since fallen.
=== Weight loss === Chitosan is marketed in a tablet form as a "fat binder". Although the effect of chitosan on lowering cholesterol and body weight has been evaluated, the effect appears to have no or low clinical importance. Reviews from 2016 and 2008 found there was no significant effect, and no justification for overweight people to use chitosan supplements. In 2015, the U.S. Food and Drug Administration issued a public advisory about supplement retailers who made exaggerated claims concerning the supposed weight loss benefit of various products.
== Education and career == Brenner graduated from Wesleyan University with a bachelor's degree in biology in 1983. After working for the biotechnology companies Chiron Corporation and DNAX Research Institute, Brenner attended graduate school at Stanford University School of Medicine. At Stanford he worked with Robert S. Fuller, receiving his Ph.D. in Cancer Biology in 1993. Brenner conducted post-doctoral research at Brandeis University with Gregory Petsko and Dagmar Ringe. Brenner then joined the faculty at Thomas Jefferson University, where he worked from 1996 to 2003, becoming Director of the Structural Biology & Bioinformatics Program in 2000. He moved to Dartmouth Medical School in 2003, serving as associate director for Basic Sciences at Norris Cotton Cancer Center (now named Dartmouth Cancer Center) from 2003 to 2009. In 2009 he joined the University of Iowa (UI) as Professor and Head of Biochemistry. In 2010 he was awarded the Roy J. Carver Chair of Biochemistry at UI, holding that position until 2020. In 2020, Brenner joined City of Hope National Medical Center in Duarte, California as the inaugural chair of a new department of diabetes and cancer metabolism created to focus at the intersection of metabolic disturbances with diseases such as cancer and diabetes.
Sources: en.wikipedia.org
It consists mainly of animal experiments and small clinical reports, with much of the clinical material published in Russian-language journals. Large independent trials are scarce. Separating reliable effects from chance findings is consequently difficult.
A fraction of an intranasal dose is thought to reach the central nervous system, and this route is favoured partly for that reason. The proportion is not well characterized. Direct measurement in humans remains difficult with current methods.
Raised BDNF and NGF expression has been reported across several animal studies, which makes the signal fairly consistent. Whether the same change occurs in humans at usable doses is not established. It is best treated as a working hypothesis rather than a confirmed clinical mechanism.
Suppliers normally quote a percentage of total chromatographic peak area, most often from reversed-phase HPLC. That figure says nothing about what the remaining percentage contains, and it depends on the detection wavelength used. A mass spectrometry result is a separate and stronger check on identity.